Pharmacological Treatments for Smoking Cessation
Tuesday, January 14, 2014
Posted by: Natalia Gromov
JAMA. 2014;311(2):193-194.
Pharmacological Treatments for Smoking Cessation.
Kate Cahill; Sarah Stevens; Tim Lancaster.
This study sought to determine among the 3 first-line smoking cessation treatments (nicotine replacement therapy [NRT], bupropion, and varenicline), which is most effective in helping people who smoke achieve and maintain abstinence from smoking for at least 6 months, and what serious adverse events are associated with each? Higher rates of smoking cessation were associated with NRT (17.6%) and bupropion (19.1%) compared with placebo (10.6%). Varenicline (27.6%) and combination NRT (31.5%) (eg, patch plus inhaler) were most effective for achieving smoking cessation. None of the therapies was associated with an increased rate of serious adverse events.
|
|
Email to a Friend